Last Day of Listing of the Shares of the Company at the ECM of the CSE
Extraordinary General Meeting
Annual General Meeting
Resignation of Mr Christakis Ierides from the office of Directors of the Company
Board of Directors Meeting to examine the Company’s 2023 Audited Consolidated Financial Statements
Allotment of 7,709 additional fully paid shares (Stock Options Exercised)
Annual Bulletin
Information on the implementation status of the Company's Business Plan/Objectives as at 31/12/2023
Board of Directors Meeting to examine the Company’s 2023 half-yearly Unaudited Consolidated Financial Statements
Annual General Meeting
Exercise Period of 7,709 Stock Options Shares
Board of Directors Meeting to examine the Company’s 2022 Audited Consolidated Financial Statements
Resignation of Mr Epaminondas Metaxas from the office of Directors of the Company
Allotment of 16,250 additional fully paid shares (Stock Options Exercised)
Annual Bulletin
Information on the implementation status of the Company's Business Plan/Objectives as at 31/12/2022
Board of Directors Meeting to examine the Company’s 2022 half-yearly Unaudited Consolidated Financial Statements
Annual General Meeting
Exercise Period of 16,250 Stock Options Shares
Board of Directors Meeting to examine the Company’s 2021 Audited Consolidated Financial Statements
Allotment of 21,129 additional fully paid shares
Annual Bulletin
Information on the implementation status of the Company's Business Plan/Objectives as at 31/12/2021
Allotment of 28,046 additional fully paid shares
Board of Directors Meeting to examine the Company’s 2021 half-yearly Unaudited Consolidated Financial Statements
Signing of Share Purchase Agreement with Dr Charis Tymvios
Appointment of Mr George Koufaris to the position of non-executive Chairman of the Board of Directors
Annual General Meeting
Allotment of 17,274 additional fully paid shares
Board of Directors Meeting to examine the Company’s 2020 Audited Consolidated Financial Statements
Annual Bulletin
Information on the implementation status of the Company's Business Plan/Objectives as at 31/12/2020
Allotment of 14,305 additional fully paid shares
Signing of Share Purchase Agreement with C.A. Papaellinas Ltd
Board of Directors Meeting to examine the Company’s 2020 half-yearly Unaudited Consolidated Financial Statements
Allotment of 36,111 additional fully paid shares
Annual General Meeting
Board of Directors Meeting to examine the Company’s 2019 Audited Consolidated Financial Statements
Signing of Share Purchase Agreement with C.A. Papaellinas Ltd
Effect of COVID-19 on the Company
Allotment of 15,278 additional fully paid shares
Decision of the Board of Directors to offer Stock Options to all the Company’s employees, directors and full time external contractors
Appointment of VGDA Accountants Limited as the Company’s new Nominated Advisor
“RichReach” has been registered as a European Union Trademark in the Register of European Union trade marks (EUIPO)
Annual Bulletin
Information on the implementation status of the Company's Business Plan/Objectives as at 31/12/2019
Allotment of 96,778 additional fully paid shares
Board of Directors Meeting to examine the Company’s 2019 half-yearly Unaudited Consolidated Financial Statements
Completion of the increase of the Company’s Authorised Ordinary Share Capital
Completion of the Appointment of Mr Epaminondas Metaxas and Mr George Koufaris at the office of Directors of the Company
Annual General Meeting
Completion of the Change of Name of “eUmbrella Corporation (International) Public Ltd” to “RichReach Corporation Public Ltd”
Notice of the Extraordinary General Meeting of 10/04/2019 at 14:00
Signing of Share Purchase Agreement with C.A. Papaellinas Ltd
Signing of Share Purchase Agreement with Cyprus Pharmaceutical Organisation Ltd
Appointment of Mr. Kyprianos Kyprianou to the position of CEO
Start of trading of the Company’s Shares at the Emerging Companies Market (ECM) of the Cyprus Stock Exchange (CSE)
Deadline for Applications regarding the Notice of Pre-Emptions Rights (raising of the issued share capital by €1,500,000) dated 10/08/2018
Annual General Meeting
Unaudited Consolidated Financial Statements of the first 6 months of 2018
Notice of Pre-Emptions Rights (raising of the issued share capital by €1,500,000)
Deadline for Applications: 17/09/2018
Completion of the increase of the Company’s Authorised and Issued Ordinary Share Capital
Unanimous written Resolution signed by all the shareholders of the Company to increase the Company’s Authorised and Issued Ordinary Share Capital.
Notice of the Extraordinary General Meeting of 18/10/2017 at 09:00 am
eUmbrella Corporation (International) Public Ltd acquires 100% of eUmbrella Corporation (CY) Ltd
Incorporation of eUmbrella Corporation (International) Public Ltd